126 related articles for article (PubMed ID: 38252040)
21. A Bayesian platform trial design to simultaneously evaluate multiple drugs in multiple indications with mixed endpoints.
Zhao Y; Tang RS; Du Y; Yuan Y
Biometrics; 2023 Jun; 79(2):1459-1471. PubMed ID: 35546501
[TBL] [Abstract][Full Text] [Related]
22. Bayesian adaptive basket trial design using model averaging.
Psioda MA; Xu J; Jiang Q; Ke C; Yang Z; Ibrahim JG
Biostatistics; 2021 Jan; 22(1):19-34. PubMed ID: 31107534
[TBL] [Abstract][Full Text] [Related]
23. Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trials.
Jiang L; Nie L; Yan F; Yuan Y
Contemp Clin Trials; 2021 Aug; 107():106460. PubMed ID: 34098036
[TBL] [Abstract][Full Text] [Related]
24. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.
Daniells L; Mozgunov P; Bedding A; Jaki T
Stat Med; 2023 Oct; 42(24):4392-4417. PubMed ID: 37614070
[TBL] [Abstract][Full Text] [Related]
25. Basket trials in oncology: a systematic review of practices and methods, comparative analysis of innovative methods, and an appraisal of a missed opportunity.
Kasim A; Bean N; Hendriksen SJ; Chen TT; Zhou H; Psioda MA
Front Oncol; 2023; 13():1266286. PubMed ID: 38033501
[TBL] [Abstract][Full Text] [Related]
26. RoBoT: a robust Bayesian hypothesis testing method for basket trials.
Zhou T; Ji Y
Biostatistics; 2021 Oct; 22(4):897-912. PubMed ID: 32061093
[TBL] [Abstract][Full Text] [Related]
27. A Bayesian basket trial design that borrows information across strata based on the similarity between the posterior distributions of the response probability.
Fujikawa K; Teramukai S; Yokota I; Daimon T
Biom J; 2020 Mar; 62(2):330-338. PubMed ID: 31608505
[TBL] [Abstract][Full Text] [Related]
28. Evidence synthesis analysis with prioritized benefit outcomes in oncology clinical trials.
Cui Y; Dong G; Kuan PF; Huang B
J Biopharm Stat; 2023 May; 33(3):272-288. PubMed ID: 36343174
[TBL] [Abstract][Full Text] [Related]
29. Bayesian Methods for Information Borrowing in Basket Trials: An Overview.
Zhou T; Ji Y
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254740
[TBL] [Abstract][Full Text] [Related]
30. Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiers.
Takeda K; Liu S; Rong A
Stat Med; 2022 Jan; 41(2):298-309. PubMed ID: 34697822
[TBL] [Abstract][Full Text] [Related]
31. An adaptive biomarker basket design in phase II oncology trials.
Liu S; Takeda K; Rong A
Pharm Stat; 2023 Jan; 22(1):128-142. PubMed ID: 36163614
[TBL] [Abstract][Full Text] [Related]
32. Bayesian and frequentist approaches to sequential monitoring for futility in oncology basket trials: A comparison of Simon's two-stage design and Bayesian predictive probability monitoring with information sharing across baskets.
Kaizer A; Zabor E; Nie L; Hobbs B
PLoS One; 2022; 17(8):e0272367. PubMed ID: 35917296
[TBL] [Abstract][Full Text] [Related]
33. Bayesian local exchangeability design for phase II basket trials.
Liu Y; Kane M; Esserman D; Blaha O; Zelterman D; Wei W
Stat Med; 2022 Sep; 41(22):4367-4384. PubMed ID: 35777367
[TBL] [Abstract][Full Text] [Related]
34. Bayesian modelling strategies for borrowing of information in randomised basket trials.
Ouma LO; Grayling MJ; Wason JMS; Zheng H
J R Stat Soc Ser C Appl Stat; 2022 Nov; 71(5):2014-2037. PubMed ID: 36636028
[TBL] [Abstract][Full Text] [Related]
35. Bayesian basket trial design with exchangeability monitoring.
Hobbs BP; Landin R
Stat Med; 2018 Nov; 37(25):3557-3572. PubMed ID: 29984488
[TBL] [Abstract][Full Text] [Related]
36. Practical basket design for binary outcomes with control of family-wise error rate.
Asano J; Sato H; Hirakawa A
BMC Med Res Methodol; 2023 Feb; 23(1):52. PubMed ID: 36849940
[TBL] [Abstract][Full Text] [Related]
37. A Multi-Arm Two-Stage (MATS) design for proof-of-concept and dose optimization in early-phase oncology trials.
Jiang Z; Mi G; Lin J; Lorenzato C; Ji Y
Contemp Clin Trials; 2023 Sep; 132():107278. PubMed ID: 37419308
[TBL] [Abstract][Full Text] [Related]
38. Optimal one-stage design and analysis for efficacy expansion in Phase I oncology trials.
Wu C; Liu F; Zhou H; Wu X; Chen C
Clin Trials; 2021 Dec; 18(6):673-680. PubMed ID: 34693772
[TBL] [Abstract][Full Text] [Related]
39. Bayesian Design for Pediatric Clinical Trials with Binary Endpoints When Borrowing Historical Information of Treatment Effect.
Jin M; Li Q; Kaur A
Ther Innov Regul Sci; 2021 Mar; 55(2):360-369. PubMed ID: 32955713
[TBL] [Abstract][Full Text] [Related]
40. Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.
Su L; Chen X; Zhang J; Yan F
JCO Precis Oncol; 2022 Mar; 6():e2100394. PubMed ID: 35263169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
